Global Medical Cold Plasma Sales Market Report 2024
The global Medical Cold Plasma market size was US$ 89.54 million in 2023 and is forecast to a readjusted size of US$ 386.26 million by 2030 with a CAGR of 21.91% during the forecast period 2024-2030.
The United States Medical Cold Plasma market size was US$ 45.5 million in 2023, while China was US$ 3.84 million. The proportion of the United States was 50.82% in 2023, while Chinese percentage was 4.29%, and it is predicted that China share will reach 5.08% in 2030, trailing a CAGR of 25.17% through the analysis period.
The global key manufacturers of Medical Cold Plasma include Apyx Medical Corporation, ADTEC Plasma Technology, Neoplas med GmbH, Terraplasma Medical GmbH, CINOGY System GmbH, D.B SkinTech, etc. are the leaders of the industry, with high-end customers. The top five manufacturers held 82.83% of the market, in terms of Medical Cold Plasma revenue in 2023
The global Medical Cold Plasma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Cold Plasma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2019-2030.
Market Segmentation
By Company
Apyx Medical Corporation
ADTEC Plasma Technology
Neoplas med GmbH
Terraplasma Medical GmbH
CINOGY System GmbH
D.B SkinTech
Segment by Type
Direct-discharge
Indirect-discharge
Segment by Application
Wound Healing
Aesthetic
Other
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Medical Cold Plasma in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Medical Cold Plasma manufacturer’s competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: The United States by company, by Type, and by Application, sales, revenue, and price for each segment.
Chapter 7: Europe by company, by Type, and by Application, sales, revenue, and price for each segment.
Chapter 8: China by company, by Type, and by Application, sales, revenue, and price for each segment.
Chapter 9: Japan by company, by Type, and by Application, sales, revenue, and price for each segment.
Chapter 10: Southeast Asia by company, by Type, and by Application, sales, revenue, and price for each segment.
Chapter 11: India by company, by Type, and by Application, sales, revenue, and price for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Cold Plasma revenue, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 14: Sales channels analysis
Chapter 15: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 16: The main points and conclusions of the report.